We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Delivery – Products

Aptamer Group Extends Collaboration With AstraZeneca To Explore Next-Generation Drug Delivery Approaches content piece image
Product News

Aptamer Group Extends Collaboration With AstraZeneca To Explore Next-Generation Drug Delivery Approaches

Aptamer Group has announced the extension of their current agreement with AstraZeneca. This agreement will further the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates.
ViaCyte and Gore Expand Collaboration  content piece image
Product News

ViaCyte and Gore Expand Collaboration

ViaCyte, Inc., and W. L. Gore & Associates, Inc., have announced an expanded joint development agreement covering the development and use of Gore materials and device capabilities to further optimize ViaCyte's product candidates for the treatment of diabetes.

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics content piece image
Product News

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics

Cybin Inc. today announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc.
First In Vivo CRISPR Treatment Delivered Intravenously to a Patient content piece image
Product News

First In Vivo CRISPR Treatment Delivered Intravenously to a Patient

Intellia Therapeutics, Inc announced that the first patient has been treated with NTLA-2001, which the company is developing as a single-course, potentially curative therapy for transthyretin amyloidosis (ATTR).
Novavax COVID-19 Vaccine Granted Fast Track Designation  content piece image
Product News

Novavax COVID-19 Vaccine Granted Fast Track Designation

Novavax, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.
Bruker’s 1 GHz NMR Spectrometer To Advance UK High-Field Solid-State NMR National Research Facility content piece image
Product News

Bruker’s 1 GHz NMR Spectrometer To Advance UK High-Field Solid-State NMR National Research Facility

Bruker today announces that its 1 GHz nuclear magnetic resonance (NMR) spectrometer has been delivered to the UK’s National Research Facility for High-Field Solid-State NMR at the University of Warwick.

BioChromato Invest In International Markets content piece image
Product News

BioChromato Invest In International Markets

BioChromato Inc. has made a major investment to expand sales, marketing and customer support activities in international markets, most notably Europe and North America.
Visualize ASO, miRNA, or siRNA with miRNAscope™ content piece image
Product
Advertisement

Visualize ASO, miRNA, or siRNA with miRNAscope™

Tailored Solutions for Exosome-related Research content piece image
Product News

Tailored Solutions for Exosome-related Research

AMSBIO is offering a comprehensive range of end-to-end services for exosome purification, characterization, and engineering.
TALLC Granted UK Patent for SmartCelle Ocular Drug Delivery Technology content piece image
Product News

TALLC Granted UK Patent for SmartCelle Ocular Drug Delivery Technology

TALLC has announced that the United Kingdom Intellectual Property Office (IPO) has granted the first in a series of SmartCelle smart micelle patents covering their novel nanotechnology for ocular drug delivery.
Advertisement